We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Generic auction

3 March 2010 By Alexander Smith

The U.S. pharma giant seems to have been lured into the battle for the German generics producer. Creditors will be happy, as both of the current bidders have reasons not to be too aggressive. But Pfizer may also be cautious. It apparently already quit the contest once.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)